Patricia Walker, M.D. specializes in the care and treatment of adults with cystic fibrosis (CF). She serves as Co-Director of Mount Sinai Beth Israel’s Cystic Fibrosis Center, and was recently appointed Acting Division Chief of Pulmonary, Critical Care and Sleep Medicine. Dr. Walker conducts and oversees a wide variety of CF clinical research, including cutting edge trials on gene modulation investigational therapies, inhaled antibiotics, and the treatment of digestive complications of CF destined to influence pulmonary outcomes. Under her direction, the CF Center was successful in obtaining distinction as a Therapeutic Development Center for CF research trials. The CF team was able to establish a nasal potential difference lab, one of only a few such centers to do so in the Northeast. The team at the CF Center has been active in developing a multidisciplinary and integrative approach to the care of CF patients. She has lectured at numerous local and international scientific meetings. Dr. Walker came to Beth Israel Medical Center from Saint Vincent’s Hospital in 2010 where she was the also the presiding Chief of Pulmonary Medicine and Co-Director of the Cystic Fibrosis Center. Dr. Walker’s medical training includes a residency in Internal Medicine at Saint Vincent’s Hospital in Manhattan, and Fellowship Training in Pulmonary and Critical Care Medicine at Memorial Sloan-Kettering Cancer Center. She is board certified in Internal Medicine, Pulmonary Disease and Palliative Care Medicine.
Language
English
Hospital Affiliations
Mount Sinai Beth Israel
The Mount Sinai Hospital
About Me
Patricia Walker, M.D. specializes in the care and treatment of adults with cystic fibrosis (CF). She serves as Co-Director of Mount Sinai Beth Israel’s Cystic Fibrosis Center, and was recently appointed Acting Division Chief of Pulmonary, Critical Care and Sleep Medicine. Dr. Walker conducts and oversees a wide variety of CF clinical research, including cutting edge trials on gene modulation investigational therapies, inhaled antibiotics, and the treatment of digestive complications of CF destined to influence pulmonary outcomes. Under her direction, the CF Center was successful in obtaining distinction as a Therapeutic Development Center for CF research trials. The CF team was able to establish a nasal potential difference lab, one of only a few such centers to do so in the Northeast. The team at the CF Center has been active in developing a multidisciplinary and integrative approach to the care of CF patients. She has lectured at numerous local and international scientific meetings. Dr. Walker came to Beth Israel Medical Center from Saint Vincent’s Hospital in 2010 where she was the also the presiding Chief of Pulmonary Medicine and Co-Director of the Cystic Fibrosis Center. Dr. Walker’s medical training includes a residency in Internal Medicine at Saint Vincent’s Hospital in Manhattan, and Fellowship Training in Pulmonary and Critical Care Medicine at Memorial Sloan-Kettering Cancer Center. She is board certified in Internal Medicine, Pulmonary Disease and Palliative Care Medicine.
Language
English
Hospital Affiliations
Mount Sinai Beth Israel
The Mount Sinai Hospital
About Me
Patricia Walker, M.D. specializes in the care and treatment of adults with cystic fibrosis (CF). She serves as Co-Director of Mount Sinai Beth Israel’s Cystic Fibrosis Center, and was recently appointed Acting Division Chief of Pulmonary, Critical Care and Sleep Medicine. Dr. Walker conducts and oversees a wide variety of CF clinical research, including cutting edge trials on gene modulation investigational therapies, inhaled antibiotics, and the treatment of digestive complications of CF destined to influence pulmonary outcomes. Under her direction, the CF Center was successful in obtaining distinction as a Therapeutic Development Center for CF research trials. The CF team was able to establish a nasal potential difference lab, one of only a few such centers to do so in the Northeast. The team at the CF Center has been active in developing a multidisciplinary and integrative approach to the care of CF patients. She has lectured at numerous local and international scientific meetings. Dr. Walker came to Beth Israel Medical Center from Saint Vincent’s Hospital in 2010 where she was the also the presiding Chief of Pulmonary Medicine and Co-Director of the Cystic Fibrosis Center. Dr. Walker’s medical training includes a residency in Internal Medicine at Saint Vincent’s Hospital in Manhattan, and Fellowship Training in Pulmonary and Critical Care Medicine at Memorial Sloan-Kettering Cancer Center. She is board certified in Internal Medicine, Pulmonary Disease and Palliative Care Medicine.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai physician communicated with them during an office visit. The Star Rating is based on patient responses to three questions on the Clinician & Group CAHPS (CG-CAHPS) Survey, a standardized questionnaire developed by Medicare. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Explains in a way you understand
4.6 out of 5
Listens carefully
4.6 out of 5
Likelihood to recommend
4.2 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Walker has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
